The China Mail - US abortion ruling threatens access to arthritis drug

USD -
AED 3.672981
AFN 62.999984
ALL 82.597888
AMD 368.060083
ANG 1.790403
AOA 916.999878
ARS 1481.256531
AUD 1.451358
AWG 1.80125
AZN 1.68207
BAM 1.71493
BBD 2.014108
BDT 123.249054
BGN 1.69088
BHD 0.377034
BIF 2975.014577
BMD 1
BND 1.293507
BOB 6.925154
BRL 5.189102
BSD 1.000039
BTN 94.490039
BWP 13.589892
BYN 2.900133
BYR 19600
BZD 2.011197
CAD 1.419815
CDF 2267.504195
CHF 0.807303
CLF 0.023428
CLP 922.060241
CNY 6.79815
CNH 6.79833
COP 3447.03
CRC 453.586914
CUC 1
CUP 26.5
CVE 96.684671
CZK 21.2308
DJF 177.720253
DKK 6.541155
DOP 59.466972
DZD 133.187486
EGP 49.201402
ERN 15
ETB 161.218522
EUR 0.87515
FJD 2.24725
FKP 0.757857
GBP 0.754305
GEL 2.644967
GGP 0.757857
GHS 11.31015
GIP 0.757857
GMD 73.000242
GNF 8766.638023
GTQ 7.629344
GYD 209.175084
HKD 7.841989
HNL 26.761891
HRK 6.593901
HTG 130.701074
HUF 309.838968
IDR 17868.95
ILS 2.98755
IMP 0.757857
INR 94.542202
IQD 1309.991977
IRR 1375250.000138
ISK 126.029814
JEP 0.757857
JMD 157.463469
JOD 0.709012
JPY 161.9355
KES 129.501624
KGS 87.45008
KHR 4021.166805
KMF 434.000271
KPW 900.00035
KRW 1541.080284
KWD 0.30956
KYD 0.833333
KZT 485.532407
LAK 22428.570802
LBP 89548.611111
LKR 336.248811
LRD 181.993547
LSL 16.430491
LTL 2.95274
LVL 0.604889
LYD 6.424601
MAD 9.371084
MDL 17.675014
MGA 4255.281837
MKD 53.944432
MMK 2099.649649
MNT 3579.92745
MOP 8.078178
MRU 39.910387
MUR 47.240213
MVR 15.450138
MWK 1734.006734
MXN 17.483585
MYR 4.071199
MZN 63.897811
NAD 16.430635
NGN 1381.869793
NIO 36.800779
NOK 9.918205
NPR 151.185701
NZD 1.769045
OMR 0.384495
PAB 1.000018
PEN 3.414923
PGK 4.390353
PHP 61.197085
PKR 278.074382
PLN 3.75255
PYG 6089.674735
QAR 3.645212
RON 4.588027
RSD 102.697996
RUB 76.998674
RWF 1467.978395
SAR 3.756538
SBD 8.051953
SCR 13.537737
SDG 599.999621
SEK 9.707925
SGD 1.292301
SHP 0.746601
SLE 24.798647
SLL 20969.503664
SOS 571.521265
SRD 37.494501
STD 20697.981008
STN 21.482654
SVC 8.749978
SYP 110.532098
SZL 16.426633
THB 33.25504
TJS 9.269869
TMT 3.5
TND 2.962063
TOP 2.40776
TRY 46.637499
TTD 6.798104
TWD 31.850497
TZS 2625.002971
UAH 44.880508
UGX 3665.2038
UYU 40.238326
UZS 12052.207233
VES 620.752985
VND 26290
VUV 119.179282
WST 2.780883
XAF 575.16627
XAG 0.017174
XAU 0.000249
XCD 2.70255
XCG 1.802247
XDR 0.716371
XOF 575.168792
XPF 104.571381
YER 238.625034
ZAR 16.408991
ZMK 9001.199474
ZMW 18.104658
ZWL 321.999592
  • RBGPF

    0.2000

    61.5

    +0.33%

  • CMSC

    0.1300

    22.06

    +0.59%

  • RYCEF

    0.0000

    18.75

    0%

  • AZN

    2.5400

    190.95

    +1.33%

  • RIO

    0.5500

    94.29

    +0.58%

  • VOD

    -0.2000

    13.69

    -1.46%

  • GSK

    0.3100

    52.81

    +0.59%

  • BP

    0.2200

    37.35

    +0.59%

  • RELX

    -0.0500

    31.29

    -0.16%

  • BTI

    -0.0200

    62.74

    -0.03%

  • NGG

    0.7500

    83.76

    +0.9%

  • CMSD

    0.1300

    21.9

    +0.59%

  • BCC

    -1.7600

    79.26

    -2.22%

  • JRI

    0.0700

    12.86

    +0.54%

  • BCE

    -0.6600

    22.26

    -2.96%

US abortion ruling threatens access to arthritis drug
US abortion ruling threatens access to arthritis drug / Photo: © POOL/AFP/File

US abortion ruling threatens access to arthritis drug

When Alabama nurse Melissa went to pick up her regular prescription for rheumatoid arthritis last week, she was told the drug was "on hold" while the pharmacist checked she wasn't going to use it to induce an abortion.

Text size:

"He said, 'Well I have to verify if you're on any contraceptives to prevent pregnancy.' The hell you do," she recalled thinking.

Melissa -- who is in her early forties and asked to be identified only by her first name for fear that speaking out might affect her livelihood -- then called her doctor, who succeeded in having the pharmacy in the southern US state release the medicine.

"I picked it up a couple hours later, but I felt violated," she told AFP, explaining she had had a hysterectomy six years ago, and that her lack of recent contraceptive history may have led the pharmacist to suspect she was pregnant.

Stories of people facing similar struggles have come to light in the weeks since the United States Supreme Court overturned Roe v Wade on June 24, highlighting an overlooked consequence of new state-level bans or severe restrictions on abortion.

It's not yet clear how widespread the cases are, but national organizations including the Lupus Foundation of America and the American College of Rheumatology said they were aware of such concerns and asking people affected to come forward.

"The Arthritis Foundation supports unencumbered access to and coverage of FDA-approved drugs for managing arthritis in alignment with scientific and clinical guidelines, as well as evidence-based medical recommendations," the organization said.

The issue centers on methotrexate, a drug which tempers inflammation and is commonly used against autoimmune conditions including inflammatory arthritis, psoriasis and lupus.

Methotrexate stops cell division and is given in higher doses as a cancer drug.

It can also sometimes be used in medical abortions, though not as frequently as the Food and Drug Administration-approved combination of two other drugs, mifepristone and misoprostol.

Nevertheless, many states have passed laws carrying threats of legal action against health care workers and pharmacies providing methotrexate.

- 'It's terrifying' -

Another woman contacted by AFP, a 20-year-old university student from Ohio, said she has had a methotrexate prescription since 2020 to treat her lupus, which affects her kidney and liver and causes joint pain.

A pharmacist at a national chain told her they were "no longer accepting prescriptions for methotrexate unless it was for the FDA-approved use of (treating) breast cancer, or the patient was not presumably fertile," she said.

She tried again, without success, to fill her prescription at a family-owned pharmacy, and this week got a letter from her doctor's office stating the practice would no longer be prescribing methotrexate because of the number of patients having difficulty accessing it.

Though the first pharmacy later changed its position, the experience left her "annoyed and angry," she said.

A third woman, 48-year-old Jennifer Crow, a writer and produce gardener in Tellico Plains, Tennessee, told AFP she received an automated call from CVS saying her methotrexate refill had been declined "pending provider approval."

Crow said Methotrexate had helped her enormously in managing her inflammatory arthritis, allowing her to roll out of bed and get dressed without severe pain, and walk without a cane for the first time in years.

Though her doctor was able to resolve the situation, Crow, who has also had a hysterectomy, said she was worried for other chronic illness patients who didn't have the same access to resources that she does.

In statements to AFP, national pharmacy chains CVS and Walmart confirmed they were working to adhere to new state regulations in light of the high court's decision to revoke the constitutional right to an abortion.

CVS added: "We encourage providers to include their diagnosis on the prescriptions they write to help ensure patients have quick and easy access to medications."

Alisa Vidulich, policy director of the Arthritis Foundation, told AFP she was hopeful the situation might be remedied quickly as medical professionals and pharmacies developed new guidelines.

"But that may not actually be the case in all states and it may in fact turn into a longer term issue," she acknowledged.

Melissa, the nurse, said she was incensed at the double standard that allowed one of her best friends, who is a man, to get his methotrexate prescription filled right away with no questions asked.

"We're headed in the wrong direction and it's terrifying. I have two daughters. I don't want to see this," she said.

F.Brown--ThChM